After all the dedicated work investigating, the PERFORM consortia along with The PIMS-TS Study Group and EUCLIDS (PERFORM's predecessor study), have published their original investigations in the paper, Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

Photo by Tim Rouen
The PERFORM consortium are optimistic their novel diagnostic approaches can accelerate the understanding of COVID-19. It has been a trying time, many aspects of our lives have changed and as we move towards an endzone, the rhetoric of ‘back to normal’ seems more likely to be a normal, version 2.0. Many research projects, especially those involving clinical research, have been abruptly stopped in their tracks by COVID-19. However the consortia of PERFORM and its cousin EU-funded project, DIAMONDS (commenced January 2020) have rapidly adapted to apply their expertise to tackling this new virus.